D-0123-2018 Class I Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-0123-2018 was initiated by Pfizer Inc. on Aug 30, 2017 and is designated Class I. Reason for recall: Presence of Particulate Matter: glass particulate found in vial The recall status is terminated (terminated Nov 8, 2018). Affected quantity: 102,500 vials.

Recall details

Product Type
Drugs
Report Date
Dec 27, 2017
Initiation Date
Aug 30, 2017
Termination Date
Nov 8, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
102,500 vials

Product description

Vancomycin Hydrochloride for Injection, USP. 750 mg. Sterile Powder. Rx Only. Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-6531-02

Reason for recall

Presence of Particulate Matter: glass particulate found in vial

Distribution pattern

Nationwide USA and Puerto Rico

Code information

Lot: 632153A; Exp. 03/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0123-2018
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0123-2018. Report a data issue: hello@regdatalab.com.